NCT00468819 - A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Magnetic Resonance Imaging

Interventions

DRUG

Gadobutrol (Gadavist, Gadovist, BAY86-4875)

In an open-label design, all patients will receive a total dose of 0.1 mmol/kg BW Gadovist 1.01 Days Injection

Trial Locations (14)

Vienna

Stockholm

Kiel

Kiel

Gothenburg

Bonn

Uppsala

Erlangen

Edmonton

Toronto

Dresden

Leipzig

Halle

Jena